The Clostridium perfringens α-toxin

Anaerobe

Volumn 5, Issue 2, 1999, Pages 51-64

  Titball, Richard W ^a   Naylor, Claire E ^b   Basak, Ajit K ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C. perfringens; Gas gangrene; Haemolysin; Phospholipase C; toxin

Indexed keywords

ALPHA TOXIN; ARACHIDONIC ACID; CALCIUM; LIPID BINDING PROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C; PHOSPHOLIPID; PROTEIN KINASE C; SPHINGOMYELIN; ZINC;

AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; BACTERIAL GENE; CELL MEMBRANE; CELL METABOLISM; CHEMICAL STRUCTURE; CHICKEN; CLOSTRIDIUM PERFRINGENS; CROHN DISEASE; EUKARYOTE; GAS GANGRENE; HEMOLYSIS; HOST CELL; HUMAN; IMMUNIZATION; NECROTIZING ENTERITIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; THROMBOCYTE AGGREGATION; VASCULARIZATION; VASOCONSTRICTION; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM PERFRINGENS; EUKARYOTA; GALLUS GALLUS;

EID: 0032850165     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1006/anae.1999.0191     Document Type: Review

References (96)

1. Willis T. A. Clostridia of Wound Infection. 1969;Butterworth and Co. London.
2. McDonel J. L. Toxins of Clostridium perfringens types A,B,C,D and E. Dorner F., Drews J. Pharmacology of Bacterial Toxins. 1986;477-517 Pergamon press, Oxford.
3. MacFarlane M. G., Knight B. C.J.G. The biochemistry of bacterial toxins I Lecithinase activity of Cl. Welchii toxins. Biochem J. 35:1941;884-902.
4. Nagahama M., Michiue K., Sakurai J. Membrane-damaging action of Clostridium perfringens alpha-toxin on phospholipid liposomes. Biochim Biophys Acta. 1280:1996;120-126.
5. Krug E. L., Kent C. Phospholipase C from Clostridium perfringens : preparation and characterisation of homogenous enzyme. Arch Biochem Biophys. 231:1984;400-410.
6. Young P. R., Snyder W. R., McMahon F. Kinetic mechanism of Clostridium perfringens phospholipase C. Biochem J. 280:1991;407-410.
7. Taguchi R., Ikezawa H. Studies on the hemolytic and hydrolytic actions of phospholipases against mammalian erythrocyte membranes. Arch Biochem biophys. 173:1976;538-545.
8. Van Deenen L. L.M., Demel R. A., Guerts van Kessel W. S.M., Kamp H. H., Roelofsen B., Verkleij A. J., Wirtz K. W.A., Zwaal R. F.A. Phospholipases and monolayers as tools in studies on membrane structure. Hatefi Y., Djavadi-Ohaniance L. The Structural Basis of Membrane Function. 1976;21-38 Academic Press, London.
9. Sakurai J., Ochi S., Tanaka H. Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes. Infect Immun. 62:1994;717-721.
10. Titball R. W., Rubidge T. The role of histidine residues in the alpha-toxin of Clostridium perfringens. FEMS Microbiol Letts. 68:1990;261-266.
11. Moreau H., Pieroni G., Jolivet-Reynaud C., Alouf J. E., Verger R. A new kinetic approach for studying phospholipase C (Clostridium perfringensα-toxin) activity on phospholipid monolayers. Biochem. 27:1988;2319-2323.
12. Canard B., Cole S. Genome organisation of the anaerobic pathogen Clostridium perfringens. Proc Nat Acad Sci USA. 86:1989;6676-6680.
13. Cole S. T., Canard B. Structure, organization and evolution of the genome of Clostridium perfringens. Rood J. I., McClane B. A., Songer J. G., Titball R. W. The Clostridia: Molecular Biology and Pathogenesis. 1997;49-63 Academic Press, London.
14. Titball R. W., Hunter S. E.C., Martin K. L., Morris B. C., Shuttleworth A. D., Rubidge T., Anderson D. W., Kelly D. C. Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens. Infect Immun. 57:1989;367-376.
15. Tso J. Y., Siebel C. Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans. Infect Immun. 57:1989;468-476.
16. Leslie D., Fairweather N., Pickard D., Dougan G., Kehoe M. Phospholipase C and haemolytic activities of Clostridium perfringens alpha-toxin cloned in Escherichia coli ; sequence and homology with a Bacillus cereus phospholipase C. Mol Microbiol. 3:1989;383-392.
17. Saint-Joanis B., Garnier T., Cole S. T. Gene cloning shows the alpha-toxin of Clostridium perfringens to contain both sphingomyelinase and lecithinase activities. Mol Gen Genet. 219:1989;453-460.
18. Okabe A., Shimizu T., Hayashi H. Cloning and sequencing of a phospholipase C gene of Clostridium perfringens. Biochem Biophys Res Commun. 160:1989;33-39.
19. Smyth C. J., Arbuthnott J. P. Properties of Clostridium perfringens (welchii) type-A a-toxin (phospholipase C) purified by electrofocusing. J Med Microbiol. 7:1974;41-67.
20. Basak A., Feam A. M., Kelly D. C., Bishop D. H.L., Stuart D. I, Titball R. W. Purification and crystallisation of the alpha-toxin (phospholipase C) of Clostridium perfringens. J Mol Biol. 244:1994;648-650.
21. Canard B., Cole S. Genome organisation of the anaerobic pathogen Clostridium perfringens. Proc Natl Acad Sci USA. 86:1989;6676-6680.
22. Lewis G. M., MacFarlane M. G. The lecithinase of C lostridium bifermentans toxin. Biochem J. 54:1953;138-142.
23. Titball R. W. Bacterial phospholipases C. Microbiol Rev. 57:1993;347-366.
24. Ottolenghi A. C. Phospholipase C from Bacillus cereus , a zinc-requiring metalloenzyme. Biochim Biophys Acta. 106:1965;510-518.
25. Geoffroy C., Raveneau J., Beretti J.-L., Lechroisey A., Vaquez-Boland J.-A., Alouf J. E., Berche P. Purification and characterisation of an extracellular 29-kilodalton phospholipase C from Listeria monocytogenes. Infect Immun. 59:1991;2382-2388.
26. Nakamura S., Shimamura T., Hayase M., Nishida S. Numerical taxonomy of saccharolytic clostridia, particularly Clostridium perfringens -like strains:descriptions of Clostridium absonum sp.n. and Clostridium paraperfringens. Int J Syst Bacteriol. 23:1973;419-429.
27. Otnaess A-B., Giercksky K. E., Prydz H. Parenteral administration of phospholipase C in the rat. Distribution, elimination, and lethal doses. Scand J Clin Lab Invest. 36:1976;553-559.
28. Naylor C. E., Eaton J. T., Howells A., Justin N., Moss D. S., Titball R. W., Basak A. K. Structure of the key toxin in gas gangrene. Nature Struct Biol. 5:1998;738-746.
29. Titball R. W., Leslie D. L., Harvey S., Kelly D. C. Haemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect Immun. 59:1991;1872-1874.
30. Nagahama M., Okagawa Y., Nakayama T., Nishioka E., Sakurai J. Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin. J Bacteriol. 177:1995;1179-1185.
31. Nagahama M., Nakayama T., Michiue K., Sakurai J. Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56 Asp-130 or Glu-152 causes loss of enzymatic and hemolytic activities. Infect Immun. 65:1997;3489-3492.
32. Guillouard I., Garnier T., Cole S. T. Use of site-directed mutagenesis to probe structure-function relationships of alpha-toxin from Clostridium perfringens. Infect Immun. 64:1996;2440-2444.
33. Nalefski E. A., Falke J. J. The C2 domain calcium-binding motif: structural and functional diversity. Protein Sci. 12:1996;2375-2390.
34. Buchanan R. E., Gibbons N. E. Bergey's Manual of Determinative Bacteriology. 1974;The Williams and Wilkins Co. Baltimore.
35. Nagahama M., Michiue K, Mukai M., Ochi S., Sakurai J. Mechanism of membrane damage of Clostridium perfringens alpha-toxin. Microbiol Immunol. 42:1998;533-538.
36. Titball R. W., Fearn A. M., Williamson E. D. Biochemical and Immunological properties of the C-terminal domain of the alpha-toxin of Clostridium perfringens. FEMS Microbiol Letts. 110:1993;45-50.
37. 2-like domain of the α-toxin from Clostridium perfringens mediates calcium-dependent membrane recognition. Mol Microbiol. 26:1997;867-876.
38. Tsutsui K., Minami J., Matsushita O., Katayama S.-I., Taniguchi Y., Nakamura S., Nishioka M., Okabe A. Phylogenetic analysis of phospholipase C genes from Clostridium perfringens types A to E and Clostridium novyi. J Bacteriol. 177:1995;7164-7170.
39. Ginter A., Williamson E. D., Dessy F., Coppe Ph., Fearn A., Titball R. W. Molecular variation between the a-toxins from the type strain (NCTC8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals. Microbiology. 142:1996;191-198.
40. Evans D. G. The in-vitro production of a-toxin, θ -haemolysin and hyaluronidase by strains of Cl. Welchii type A, and the relationship of in-vitro properties to virulence for guinea-pigs. J Path Bact. 57:1945;77-85.
41. Möllby R., Holme T., Nord C.-E., Smyth C. J., Wadström T. Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. J Gen Microbiol. 96:1976;137-144.
42. Bullifent H. L., Moir A., Awad M. M., Scott P. T., Rood J. I., Titball R. W. The level of expression of α-toxin by different strains of Clostridium perfringens is dependent on differences in promoter structure and genetic background. Anaerobe. 2:1996;365-371.
43. Toyonaga T., Matsushita O., Katayama S.-I., Minami J., Okabe A. Role of the upstream region containing an intrinsic DNA curvature in the negative regulation of the phospholipase C gene of Clostridium perfringens. Microbiol Immunol. 36:1992;603-613.
44. Matsushita C., Matsushita O., Katayama S., Minami J., Takai K., Okabe A. An upstream activating sequence containing curved DNA involved in activation of the Clostridium perfringens p/c promoter. Microbiology. 142:1996;2561-2566.
45. Ba-Thein W., Lyristis M., Ohtani K., Nisbet I. T., Hayashi H., Rood J. I., Shimizu T. The virR/virS locus regulates the transcription of genes encoding extracellular toxin production inClostridium perfringens. J. Bacteriol. 178:1996;2514-2520.
46. Lyristis M., Bryant A. E., Sloan J., Awad M. M., Nisbet I. T., Stevens D. L., Rood J. I. Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens. Mol Microbiol. 12:1994;761-777.
47. MacLennan J. D. The histotoxic Clostridial infections of man. Bact Rev. 26:1962;77-274.
48. McNee J. W., Dunn J. S. The method of spread of gas gangrene into living muscle. Br Med J. 1:1917;727-729.
49. Ninomiya M., Matsushita O., Minami J., Sakamoto H., Nakano M., Okabe A. Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis. Infect Immun. 62:1994;5032-5039.
50. Awad M. M., Bryant A. E., Stevens D. L., Rood J. I. Virulence studies on chromosomal α-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of a-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol. 15:1995;191-202.
51. Williamson E. D., Titball R. W. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens also protects mice against experimental gas gangrene. Vaccine. 11:1993;1253-1258.
52. Baba E., Fuller A. L., Gilbert J. M., Thayer S. G., McDougald L. R. Effects of Eimeria brunetti infection and dietary zinc on experimental induction of necrotic enteritis in broiler chickens. Avian Dis. 36:1992;59-62.
53. Cygan Z., Buczek J. Nonenterotoxigenic anaerobe C. perfringens A as a cause of calf diarrhoea. Medycyna Wet. 49:1993;469-471.
54. Johannsen U., Arnold P., Köhler B., Selbitz H. J. Untersuchungen zur experimentelien Chlostridium-perfringens- Typ-A-Enterotoxämie der Saugferkel. Mh Vet-Med. 48:1993;129-136.
55. Murrell W. G., Stewart B. J., O'Neil C., Siarkas S., Kariks S. Enterotoxigenic bacteria in the sudden infant death syndrome. J Med Microbiol. 39:1993;114-127.
56. Long J. R., Truscott R. B. Necrotic enteritis in broiler chickens. III Reproduction of the disease. Can J Comp Med. 40:1976;53-59.
57. Sato H., Yamakawa Y., Ito A., Murata A. Effect of zinc and calcium ions on the production of alpha-toxin and proteases by Clostridium perfringens. Infect Immun. 20:1978;325-333.
58. Siarakas S., Damas E., Murrell W. G. The effect of enteric bacterial toxins on the catecholamine levels of the rabbit. Pathology. 29:1997;278-285.
59. Gustafson C., Sjodahl R., Tagesson C. Phospholipase C activation and arachidonic acid release in intestinal epithelial cells from patients with Crohn's disease. Scand J Gastroenterol. 25:1990;1151-1160.
60. Olhagen B. Intestinal Clostridium perfringens in arthritis and allied conditions. Dumonde D. C. Infection and Immunology in the Rheumatic Disease. 1976;141-145 Blackwell Scientific Publications.
61. Hübl W., Mostbeck B., Hartleb H., Pointner H., Kofler K., Bayer P. M. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann Hematol. 67:1993;145-147.
62. Strunk S. W., Smith C. W., Blumberg J. M. Ultrastructural changes on the lesion produced in skeletal muscle fibres by C. welchii type A toxin. Am J Pathol. 50:1967;89-107.
63. Bryant A. E., Bergstrom R., Zimmerman G. A., Salyer J. L., Hill H. R., Tweten R. K., Sato H., Stevens D. L. Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function:the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol. 7:1993;321-336.
64. Bryant A. E., Stevens D. L. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun. 64:1996;358-362.
65. Stevens D. L., Tweten T. K., Awad M. M., Rood J. I., Bryant A. E. Clostridial gas gangrene: evidence that α and θ toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis. 176:1997;189-195.
66. Bunting M., Lorant D. E., Bryant A. E., Zimmerman G. A., Mclntyre T. M., Stevens D. L., Prescott S. M. Alpha-toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J clin Invest. 100:1997;565-574.
67. Fujii Y., Sakurai J. Contraction of the rat isolated aorta caused by Clostridium perfringens alpha-toxin (phospholipase C); evidence for the involvement of arachidonic acid metabolism. Br J Pharmacol. 97:1989;119-124.
68. Gustafson C., Tagesson C. Phospholipase C from Clostridium perfringens stimulates phospholipase A 2 -mediated arachidonic acid release in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol. 25:1990;363-371.
69. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 220:1983;568-575.
70. Kald B., Boll R.-M., Gustaffson-Svard C., Sjodahl R., Tagesson C. Phospholipase C from Clostridium perfringens stimulates acetyltransferase-dependent formation of platelet-activating factor in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol. 29:1994;243-247.
71. Whatley R. E., Nelson P., Zimmerman G. A., Stevens D. L., Parker C. J., Mclntyre T. M., Prescott S. M. The regulation of platelet-activating factor production in endothelial cells. J Biol Chem. 264:1989;6325-6333.
72. Sugahara T., Takahashi T., Yamaya S., Ohsaka A. In vitro aggregation of platelets induced by alpha-toxin (phospholipase C) of Clostridium perfringens. Jap J Med Sci Biol. 29:1976;255-263.
73. Ochi S., Hashimoto K., Nagahama M., Sakurai J. Phospholipid metabolism induced by Clostridium perfringens alpha-toxin elicits a hot-cold type of hemolysis in rabbit erythrocytes. Infect Immun. 64:1996;3930-3933.
74. Sakurai J., Ochi S., Tanaka H. Evidence for coupling of Clostridium perfringens alpha-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes. Infect Immun. 61:1993;3711-3718.
75. Exton J. H. Signalling through phosphatidylcholine breakdown. J Biol Chem. 265:1990;1-4.
76. Fujii Y., Nomura S., Oshita Y., Sakurai J. Excitatory effect of Clostridium perfringens alpha toxin on the rat isolated aorta. Br J Pharmacol. 88:1986;531-539.
77. Boethius J., Rydqvist B., Möllby R., Wadström T. Effect of a highly purified phospholipase C on some electrophysiological properties of the frog muscle fibre membrane. Life Sci. 13:1973;171-176.
78. Sakurai J., Fujii Y., Shirotani M. Contraction induced by Clostridium perfringens alpha-toxin in the isolated rat ileum. Toxicon. 28:1990;411-418.
79. Asmuth D. M., Olson R. D., Hackett S. P., Bryant A. E., Tweten R. K., Tso J. Y., Zollerman T., Stevens D. L. Effects of Clostridium perfringens recombinant and crude phospholipase C and θ -toxin on rabbit hemodynamic parameters. J Infect Dis. 172:1995;1317-1323.
80. Flores-Díaz M., Alape-Girón A., Persson B., Pollosello P., Moos M., von Eichel-Streiber C., Thelestam M., Florin I. Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene. J Biol Chem. 272:1997;23784-23791.
81. Flores-Díaz M., Alape-Girón A., Titball R. W., Moos M., Guillouard I., Cole S., Howells A. M., von Eichel-Streiber C., Thelestam M. UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipaseC. J Biol Chem. 273:1998;24433-24438.
82. Owen-Smith M. S. Successful prophylaxis of gas gangrene of the high-velocity missile wound in sheep. Br J Surg. 55:1968;36-39.
83. Roberston M., Keppie J. Gas gangrene. Active immunisation by means of concentrated toxoids. Lancet. ii:1943;311-314.
84. Boyd N. A., Thomson R. O., Walker P. D. The prevention of experimental Clostridium novyi and Cl . perfringens gas gangrene in high-velocity missile wounds by active immunisation. J Med Microbiol. 5:1972;467-472.
85. Kameyama S., Sato H., Murata R. The role of a-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs. Jap J Med Sci Biol. 25:1975;200.
86. Ito A. Purification and toxoiding of a-toxin of Cl. Perfringens (welchii). Jap J Med Sci Biol. 21:1968;379-391.
87. MacLennan J. D. Anaerobic infections in war wounds in the middle east. Lancet. 63:1943;94-99.
88. Conway H. Anaerobic infection and gangrene of war wounds in casualties from the Philippine Islands. Surgery. 19:1946;553-561.
89. North J. P. Clostridial wound infection and gas gangrene. Surgery. 21:1947;364-372.
90. Logan A. J., Williamson E. D., Titball R. W, Percival D. A., Shuttleworth A. D., Conlan J. W., Kelly D. C. Epitope mapping of the alpha-toxin of Clostridium perfringens. Infect Immun. 59:1991;4338-4342.
91. Sato H., Chiba J., Sato Y. Monoclonal antibodies against alpha toxin of Clostridium perfringens. FEMS Microbiol Letts. 59:1989;173-176.
92. Schoepe H, Wieler L. H., Bauerfeind R., Schlapp T., Potschka H., Hehnen H.-R., Baljer G. neutralisation of hemolytic and mouse lethal activities of C.perfringens alpha-toxin need simultaneous blockade or two epitopes by monoclonal antibodies. Microbial Path. 23:1997;1-10.
93. Chovnick A., Schneider W. P., Tso J. Y., Queen C., Chang C. N. A recombinant membrane-acting immunotoxin. Cancer Res. 51:1991;465-467.
94. Carter G., White P., Fernie P., King S., Hamilton A., McLean G., Titball R. W., Carr F. J. Enhanced antitumour effect of liposomal daunorubicin using antibody-phospholipase C conjugates or fusion protein. Int J Oncol. 13:1998;819-825.
95. Titball R. W. Bacterial Phospholipases. J Appl Microbiol. 84:1998;127S-137S.
96. Songer J. G. Bacterial phospholipases and their role in virulence. Trends Microbiol. 5:1997;156-161.